Efficacy and safety of a biogeneric recombinant human erythropoietin in the management of chemotherapy-induced anemia: a randomized double-blind active-comparator trial
Crossref DOI link: https://doi.org/10.1007/s00580-015-2158-0
Published Online: 2015-07-23
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Panahi, Yunes
Saadat, Alireza
Imani, Saber
Sahebkar, Amirhossein
Text and Data Mining valid from 2015-07-23